{"transactions":[{"id":4624602,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-22T20:15:24.000Z","date":"2026-09-21","kind":"grant","planned":false,"acquired":true,"shares":4.2565,"price":1164.89,"value":4958.354285,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":3012.4473,"source":{"system":"sec-edgar","filing":"0001262388-26-000018","document":"wk-form4_1790108122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262388/000126238826000018/wk-form4_1790108122.xml","form_type":"4"}},{"id":5619,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-18T20:24:52.000Z","date":"2026-08-17","kind":"grant","planned":false,"acquired":true,"shares":4.1908,"price":1183.16,"value":4958.386928,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":3003.9096,"source":{"system":"sec-edgar","filing":"0001262388-26-000016","document":"wk-form4_1787084689.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000126238826000016/wk-form4_1787084689.xml","form_type":"4"}},{"id":6593,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-21T20:40:34.000Z","date":"2026-07-20","kind":"grant","planned":false,"acquired":true,"shares":4.3232,"price":1146.9,"value":4958.27808,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2999.7188,"source":{"system":"sec-edgar","filing":"0001262388-26-000014","document":"wk-form4_1784666431.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000126238826000014/wk-form4_1784666431.xml","form_type":"4"}},{"id":7462,"issuer":{"id":1763,"kind":"organization","name":"Mastercard Inc","symbol":"MA"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:04:42.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock unit award that was fully vested on June 16, 2026, the date of grant, but will settle upon termination of service by the reporting person as a director."}],"balance_after":5845,"source":{"system":"sec-edgar","filing":"0001141391-26-000055","document":"wk-form4_1781813080.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1141391/000114139126000055/wk-form4_1781813080.xml","form_type":"4"}},{"id":7614,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:25:41.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":4.3904,"price":1129.35,"value":4958.29824,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2995.3956,"source":{"system":"sec-edgar","filing":"0001262388-26-000012","document":"wk-form4_1781641539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000126238826000012/wk-form4_1781641539.xml","form_type":"4"}},{"id":9611,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-19T20:19:57.000Z","date":"2026-05-18","kind":"grant","planned":false,"acquired":true,"shares":5.018,"price":988.09,"value":4958.23562,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2986.617,"source":{"system":"sec-edgar","filing":"0001262388-26-000010","document":"wk-form4_1779221994.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000126238826000010/wk-form4_1779221994.xml","form_type":"4"}},{"id":10641,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-21T20:20:53.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":5.39,"price":919.9,"value":4958.261,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2981.599,"source":{"system":"sec-edgar","filing":"0001262388-26-000008","document":"wk-form4_1776802850.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000126238826000008/wk-form4_1776802850.xml","form_type":"4"}},{"id":11811,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T20:32:31.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":5.013,"price":989.12,"value":4958.45856,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2976.209,"source":{"system":"sec-edgar","filing":"0001262388-26-000006","document":"wk-form4_1773779547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000126238826000006/wk-form4_1773779547.xml","form_type":"4"}},{"id":13374,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-18T21:27:23.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":4.786,"price":1036.05,"value":4958.5353,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2966.222,"source":{"system":"sec-edgar","filing":"0001262388-26-000004","document":"wk-form4_1771450040.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000126238826000004/wk-form4_1771450040.xml","form_type":"4"}},{"id":15235,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-21T21:27:00.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":4.762,"price":1041.29,"value":4958.62298,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2961.436,"source":{"system":"sec-edgar","filing":"0001262388-26-000002","document":"wk-form4_1769030817.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000126238826000002/wk-form4_1769030817.xml","form_type":"4"}},{"id":16060,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-16T21:46:39.000Z","date":"2025-12-15","kind":"grant","planned":false,"acquired":true,"shares":4.668,"price":1062.19,"value":4958.30292,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2956.674,"source":{"system":"sec-edgar","filing":"0001262388-25-000010","document":"wk-form4_1765921596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000126238825000010/wk-form4_1765921596.xml","form_type":"4"}},{"id":17094,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T21:26:43.000Z","date":"2025-11-17","kind":"grant","planned":false,"acquired":true,"shares":215.327,"price":1021.7,"value":219999.5959,"ownership":{"direct":true},"balance_after":2948.32,"source":{"system":"sec-edgar","filing":"0001262388-25-000008","document":"wk-form4_1763501198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000126238825000008/wk-form4_1763501198.xml","form_type":"4"}},{"id":17093,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T21:26:43.000Z","date":"2025-11-17","kind":"grant","planned":false,"acquired":true,"shares":4.853,"price":1021.7,"value":4958.3101,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares reported as acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2732.993,"source":{"system":"sec-edgar","filing":"0001262388-25-000008","document":"wk-form4_1763501198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000126238825000008/wk-form4_1763501198.xml","form_type":"4"}},{"id":17955,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-22T20:24:57.000Z","date":"2025-10-20","kind":"grant","planned":false,"acquired":true,"shares":6.129,"price":808.96,"value":4958.11584,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2728.14,"source":{"system":"sec-edgar","filing":"0001262388-25-000006","document":"wk-form4_1761164695.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000126238825000006/wk-form4_1761164695.xml","form_type":"4"}},{"id":19620,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-17T20:49:54.000Z","date":"2025-09-15","kind":"grant","planned":false,"acquired":true,"shares":6.627,"price":748.19,"value":4958.25513,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2721.97,"source":{"system":"sec-edgar","filing":"0001262388-25-000004","document":"wk-form4_1758142191.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000126238825000004/wk-form4_1758142191.xml","form_type":"4"}},{"id":20723,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T20:23:12.000Z","date":"2025-08-18","kind":"grant","planned":false,"acquired":true,"shares":7.103,"price":698.05,"value":4958.24915,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2710.158,"source":{"system":"sec-edgar","filing":"0000059478-25-000232","document":"wk-form4_1755634987.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947825000232/wk-form4_1755634987.xml","form_type":"4"}},{"id":20911,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T20:19:09.000Z","date":"2025-08-12","kind":"purchase","planned":false,"acquired":true,"shares":117,"price":641.182,"value":75018.294,"ownership":{"direct":true},"balance_after":2703.055,"source":{"system":"sec-edgar","filing":"0000059478-25-000212","document":"wk-form4_1755029946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947825000212/wk-form4_1755029946.xml","form_type":"4"}},{"id":21621,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-22T20:55:32.000Z","date":"2025-07-21","kind":"grant","planned":false,"acquired":true,"shares":6.505,"price":762.18,"value":4957.9809,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2586.055,"source":{"system":"sec-edgar","filing":"0000059478-25-000194","document":"wk-form4_1753217727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947825000194/wk-form4_1753217727.xml","form_type":"4"}},{"id":22436,"issuer":{"id":1763,"kind":"organization","name":"Mastercard Inc","symbol":"MA"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-26T20:33:25.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock unit award that was fully vested on June 24, 2025, the date of grant, but will settle upon termination of service by the reporting person as a director."}],"balance_after":5336,"source":{"system":"sec-edgar","filing":"0001141391-25-000150","document":"wk-form4_1750969990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1141391/000114139125000150/wk-form4_1750969990.xml","form_type":"4"}},{"id":22747,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-17T22:28:26.000Z","date":"2025-06-16","kind":"grant","planned":false,"acquired":true,"shares":6.14,"price":807.58,"value":4958.5412,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2579.55,"source":{"system":"sec-edgar","filing":"0000059478-25-000176","document":"wk-form4_1750199300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947825000176/wk-form4_1750199300.xml","form_type":"4"}},{"id":23821,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-20T20:25:40.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":6.566,"price":755.11,"value":4958.05226,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2568.651,"source":{"system":"sec-edgar","filing":"0000059478-25-000154","document":"wk-form4_1747772733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947825000154/wk-form4_1747772733.xml","form_type":"4"}},{"id":24916,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-22T20:22:49.000Z","date":"2025-04-21","kind":"grant","planned":false,"acquired":true,"shares":6.061,"price":818.02,"value":4958.01922,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2562.085,"source":{"system":"sec-edgar","filing":"0000059478-25-000124","document":"wk-form4_1745353361.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947825000124/wk-form4_1745353361.xml","form_type":"4"}},{"id":25639,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-19T20:27:54.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":6.012,"price":824.76,"value":4958.45712,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2556.024,"source":{"system":"sec-edgar","filing":"0000059478-25-000103","document":"wk-form4_1742416067.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947825000103/wk-form4_1742416067.xml","form_type":"4"}},{"id":27964,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-19T21:23:37.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":5.784,"price":857.2,"value":4958.0448,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2545.394,"source":{"system":"sec-edgar","filing":"0000059478-25-000077","document":"wk-form4_1740000210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947825000077/wk-form4_1740000210.xml","form_type":"4"}},{"id":30017,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-23T21:24:36.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":6.679,"price":742.35,"value":4958.15565,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2539.61,"source":{"system":"sec-edgar","filing":"0000059478-25-000016","document":"wk-form4_1737667469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947825000016/wk-form4_1737667469.xml","form_type":"4"}},{"id":31506,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-17T21:23:10.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":12.73,"price":779,"value":9916.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2532.931,"source":{"system":"sec-edgar","filing":"0000059478-24-000291","document":"wk-form4_1734470584.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000291/wk-form4_1734470584.xml","form_type":"4"}},{"id":33644,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-20T21:28:51.000Z","date":"2024-11-18","kind":"grant","planned":false,"acquired":true,"shares":302.53,"price":727.2,"value":219999.816,"ownership":{"direct":true},"balance_after":2516.624,"source":{"system":"sec-edgar","filing":"0000059478-24-000276","document":"wk-form4_1732138122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000276/wk-form4_1732138122.xml","form_type":"4"}},{"id":33643,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-20T21:28:51.000Z","date":"2024-11-18","kind":"grant","planned":false,"acquired":true,"shares":13.637,"price":727.2,"value":9916.8264,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2214.094,"source":{"system":"sec-edgar","filing":"0000059478-24-000276","document":"wk-form4_1732138122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000276/wk-form4_1732138122.xml","form_type":"4"}},{"id":34538,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-22T20:23:27.000Z","date":"2024-10-21","kind":"grant","planned":false,"acquired":true,"shares":11,"price":906.13,"value":9967.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2201,"source":{"system":"sec-edgar","filing":"0000059478-24-000238","document":"wk-form4_1729628600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000238/wk-form4_1729628600.xml","form_type":"4"}},{"id":35514,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T21:19:21.000Z","date":"2024-09-16","kind":"grant","planned":false,"acquired":true,"shares":11,"price":923.54,"value":10158.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2190,"source":{"system":"sec-edgar","filing":"0000059478-24-000225","document":"wk-form4_1726607955.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000225/wk-form4_1726607955.xml","form_type":"4"}},{"id":36670,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-20T20:18:16.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":11,"price":921.81,"value":10139.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2176,"source":{"system":"sec-edgar","filing":"0000059478-24-000206","document":"wk-form4_1724185087.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000206/wk-form4_1724185087.xml","form_type":"4"}},{"id":1440908,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-05T16:32:15.000Z","date":"2024-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":95242,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"At the Effective Time, each outstanding option, whether vested or unvested, was cancelled and converted into the right to receive an amount of cash equal to the product of (i) the aggregate number of common stock underlying such option immediately prior to the Effective Time, multiplied by (ii) the amount, if any, by which the Merger Consideration exceeds the exercise price per share of such option, subject to any applicable withholding taxes and in accordance with the terms of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding option, whether vested or unvested, was cancelled and converted into the right to receive an amount of cash equal to the product of (i) the aggregate number of common stock underlying such option immediately prior to the Effective Time, multiplied by (ii) the amount, if any, by which the Merger Consideration exceeds the exercise price per share of such option, subject to any applicable withholding taxes and in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding option, whether vested or unvested, was cancelled and converted into the right to receive an amount of cash equal to the product of (i) the aggregate number of common stock underlying such option immediately prior to the Effective Time, multiplied by (ii) the amount, if any, by which the Merger Consideration exceeds the exercise price per share of such option, subject to any applicable withholding taxes and in accordance with the terms of the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"At the Effective Time, each outstanding option, whether vested or unvested, was cancelled and converted into the right to receive an amount of cash equal to the product of (i) the aggregate number of common stock underlying such option immediately prior to the Effective Time, multiplied by (ii) the amount, if any, by which the Merger Consideration exceeds the exercise price per share of such option, subject to any applicable withholding taxes and in accordance with the terms of the Merger Agreement."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":95242},"source":{"system":"sec-edgar","filing":"0000950170-24-090833","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024090833/ownership.xml","form_type":"4"}},{"id":1440907,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T16:32:15.000Z","date":"2024-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10461,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are represented by restricted stock units (\"RSUs\"). At the Effective Time, each outstanding award of RSUs was cancelled and converted into the right to receive an amount in cash equal to the product of the aggregate number of shares underlying such RSU immediately prior to the Effective Time, multiplied by the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares are represented by restricted stock units (\"RSUs\"). At the Effective Time, each outstanding award of RSUs was cancelled and converted into the right to receive an amount in cash equal to the product of the aggregate number of shares underlying such RSU immediately prior to the Effective Time, multiplied by the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-090833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024090833/ownership.xml","form_type":"4"}},{"id":1440906,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T16:32:15.000Z","date":"2024-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":48415,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated December 6, 2023, by and among AbbVie Inc. (\"Parent\"), Symphony Harlan LLC, Symphony Harlan Merger Sub Inc. (\"Merger Sub\") and Cerevel Therapeutics Holdings, Inc. (\"Issuer\"), on August 1, 2024 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock was cancelled and converted into the right to receive $45.00 in cash (the \"Merger Consideration\"), without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated December 6, 2023, by and among AbbVie Inc. (\"Parent\"), Symphony Harlan LLC, Symphony Harlan Merger Sub Inc. (\"Merger Sub\") and Cerevel Therapeutics Holdings, Inc. (\"Issuer\"), on August 1, 2024 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock was cancelled and converted into the right to receive $45.00 in cash (the \"Merger Consideration\"), without interest."}],"balance_after":10461,"source":{"system":"sec-edgar","filing":"0000950170-24-090833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024090833/ownership.xml","form_type":"4"}},{"id":38012,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-16T20:22:52.000Z","date":"2024-07-15","kind":"grant","planned":false,"acquired":true,"shares":10,"price":950.46,"value":9504.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2165,"source":{"system":"sec-edgar","filing":"0000059478-24-000174","document":"wk-form4_1721161365.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000174/wk-form4_1721161365.xml","form_type":"4"}},{"id":39147,"issuer":{"id":1763,"kind":"organization","name":"Mastercard Inc","symbol":"MA"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-21T19:50:24.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock unit award that was fully vested on June 18, 2024, the date of grant, but will be settled upon termination of service by the reporting person as a director."}],"balance_after":4878,"source":{"system":"sec-edgar","filing":"0001141391-24-000149","document":"wk-form4_1718999417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1141391/000114139124000149/wk-form4_1718999417.xml","form_type":"4"}},{"id":39413,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T20:23:02.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":11,"price":885.01,"value":9735.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2155,"source":{"system":"sec-edgar","filing":"0000059478-24-000156","document":"wk-form4_1718742175.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000156/wk-form4_1718742175.xml","form_type":"4"}},{"id":1483240,"issuer":{"id":4234,"kind":"organization","name":"Warby Parker Inc.","symbol":"WRBY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-12T01:30:36.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":14793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of fully-vested restricted stock units (\"RSUs\"), granted pursuant to the Warby Parker Inc. Amended and Restated Non-Employee Director Compensation Program. Each RSU represents a right to receive one share of Class A Common Stock. The RSUs will be settled in shares of Class A Common Stock following the earliest to occur of: (i) the director's separation from service; (ii) a change in control of the Issuer; or (iii) the director's death."}],"balance_after":84024,"source":{"system":"sec-edgar","filing":"0001104659-24-070568","document":"tm2417040-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262388/000110465924070568/tm2417040-7_4seq1.xml","form_type":"4"}},{"id":1486981,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T16:28:36.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":10461,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. 100% of the RSUs subject to this grant shall vest upon the earlier of: (i) the one-year anniversary of the Grant Date, or (ii) the 2025 annual meeting of stockholders of the Company."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. 100% of the RSUs subject to this grant shall vest upon the earlier of: (i) the one-year anniversary of the Grant Date, or (ii) the 2025 annual meeting of stockholders of the Company."}],"balance_after":58876,"source":{"system":"sec-edgar","filing":"0000950170-24-070694","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024070694/ownership.xml","form_type":"4"}},{"id":40658,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T20:24:32.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":13,"price":783.18,"value":10181.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2141,"source":{"system":"sec-edgar","filing":"0000059478-24-000137","document":"wk-form4_1716323062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000137/wk-form4_1716323062.xml","form_type":"4"}},{"id":41776,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-16T20:14:50.000Z","date":"2024-04-15","kind":"grant","planned":false,"acquired":true,"shares":13,"price":750.77,"value":9760.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2128,"source":{"system":"sec-edgar","filing":"0000059478-24-000111","document":"wk-form4_1713298480.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000111/wk-form4_1713298480.xml","form_type":"4"}},{"id":42997,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-19T20:23:33.000Z","date":"2024-03-18","kind":"grant","planned":false,"acquired":true,"shares":13,"price":762.66,"value":9914.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2115,"source":{"system":"sec-edgar","filing":"0000059478-24-000092","document":"wk-form4_1710879793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000092/wk-form4_1710879793.xml","form_type":"4"}},{"id":45378,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-21T21:26:36.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":13,"price":755.66,"value":9823.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2098,"source":{"system":"sec-edgar","filing":"0000059478-24-000075","document":"wk-form4_1708550776.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000075/wk-form4_1708550776.xml","form_type":"4"}},{"id":1646411,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-13T16:16:33.000Z","date":"2023-08-29","kind":"gift","planned":false,"acquired":true,"shares":562,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48415,"source":{"system":"sec-edgar","filing":"0000950170-24-014586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024014586/ownership.xml","form_type":"5"}},{"id":48489,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-17T21:19:03.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":16,"price":634.57,"value":10153.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2085,"source":{"system":"sec-edgar","filing":"0000059478-24-000010","document":"wk-form4_1705526334.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000010/wk-form4_1705526334.xml","form_type":"4"}},{"id":49555,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-19T21:16:46.000Z","date":"2023-12-18","kind":"grant","planned":false,"acquired":true,"shares":9,"price":579.76,"value":5217.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":2069,"source":{"system":"sec-edgar","filing":"0000059478-23-000328","document":"wk-form4_1703020592.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000328/wk-form4_1703020592.xml","form_type":"4"}},{"id":50980,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T21:30:50.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":335,"price":597.6,"value":200196.0,"ownership":{"direct":true},"balance_after":2057,"source":{"system":"sec-edgar","filing":"0000059478-23-000312","document":"wk-form4_1700602226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000312/wk-form4_1700602226.xml","form_type":"4"}},{"id":50979,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T21:30:50.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":8,"price":597.6,"value":4780.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":1722,"source":{"system":"sec-edgar","filing":"0000059478-23-000312","document":"wk-form4_1700602226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000312/wk-form4_1700602226.xml","form_type":"4"}},{"id":52096,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-17T20:24:30.000Z","date":"2023-10-16","kind":"grant","planned":false,"acquired":true,"shares":8,"price":616.64,"value":4933.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":1714,"source":{"system":"sec-edgar","filing":"0000059478-23-000276","document":"wk-form4_1697574262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000276/wk-form4_1697574262.xml","form_type":"4"}},{"id":52557,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-20T20:29:29.000Z","date":"2023-09-18","kind":"grant","planned":false,"acquired":true,"shares":9,"price":571.28,"value":5141.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":1706,"source":{"system":"sec-edgar","filing":"0000059478-23-000261","document":"wk-form4_1695241761.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000261/wk-form4_1695241761.xml","form_type":"4"}},{"id":53382,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-22T20:33:35.000Z","date":"2023-08-21","kind":"grant","planned":false,"acquired":true,"shares":9,"price":550.5,"value":4954.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":1694,"source":{"system":"sec-edgar","filing":"0000059478-23-000237","document":"wk-form4_1692736404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000237/wk-form4_1692736404.xml","form_type":"4"}},{"id":54356,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-18T20:43:57.000Z","date":"2023-07-17","kind":"grant","planned":false,"acquired":true,"shares":11,"price":447.14,"value":4918.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":1685,"source":{"system":"sec-edgar","filing":"0000059478-23-000215","document":"wk-form4_1689713028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000215/wk-form4_1689713028.xml","form_type":"4"}},{"id":54658,"issuer":{"id":1763,"kind":"organization","name":"Mastercard Inc","symbol":"MA"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-29T21:29:09.000Z","date":"2023-06-27","kind":"grant","planned":false,"acquired":true,"shares":642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock unit award that was fully vested on June 27, 2023, the date of grant, but will be settled upon termination of the reporting person's service as a director."}],"balance_after":4333,"source":{"system":"sec-edgar","filing":"0001141391-23-000120","document":"wk-form4_1688074138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1141391/000114139123000120/wk-form4_1688074138.xml","form_type":"4"}},{"id":54871,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-21T20:28:57.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":11,"price":451.95,"value":4971.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":1674,"source":{"system":"sec-edgar","filing":"0000059478-23-000200","document":"wk-form4_1687379325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000200/wk-form4_1687379325.xml","form_type":"4"}},{"id":1858557,"issuer":{"id":4234,"kind":"organization","name":"Warby Parker Inc.","symbol":"WRBY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-12T21:38:14.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":23116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of fully-vested restricted stock units (\"RSUs\"), granted pursuant to the Warby Parker Inc. Amended and Restated Non-Employee Director Compensation Program. Each RSU represents a right to receive one share of Class A Common Stock. The RSUs will be settled in shares of Class A Common Stock following the earliest to occur of: (i) the director's separation from service; (ii) a change in control of the Issuer; (iii) the director's death; or (iv) December 7, 2027."}],"balance_after":69231,"source":{"system":"sec-edgar","filing":"0001104659-23-070467","document":"tm2318444-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262388/000110465923070467/tm2318444-6_4seq1.xml","form_type":"4"}},{"id":1860747,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T16:51:52.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":13780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to this option shall vest and become exercisable on the earlier of: (i) the one-year anniversary of the Grant Date, or (ii) the next annual meeting of stockholders of the Company occurring after the Grant Date."}],"balance_after":13780,"derivative":{"exercise_price":32.6,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":13780},"source":{"system":"sec-edgar","filing":"0000899243-23-015197","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805387/000089924323015197/doc4.xml","form_type":"4"}},{"id":1860746,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T16:51:52.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":3282,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. 100% of the RSUs subject to this grant shall vest upon the earlier of: (i) the one-year anniversary of the Grant Date, or (ii) the next annual meeting of stockholders of the Company occurring after the Grant Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. 100% of the RSUs subject to this grant shall vest upon the earlier of: (i) the one-year anniversary of the Grant Date, or (ii) the next annual meeting of stockholders of the Company occurring after the Grant Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 7, 2023, BC Perception Holdings, LP (\"BC Perception\") distributed an aggregate of 432,627 shares of Common Stock to certain of its limited partners (including the Reporting Person) in a pro-rata in-kind distribution to such limited partners in connection with a redemption of their partnership interests. Includes 30,301 shares of Common Stock received by the Reporting Person in the distribution described herein made in accordance with the exemptions afforded under Rule 16a-9(a) and Rule 16a-13 of the Securities Exchange Act of 1934, as amended."}],"balance_after":47853,"source":{"system":"sec-edgar","filing":"0000899243-23-015197","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805387/000089924323015197/doc4.xml","form_type":"4"}},{"id":55938,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-16T20:29:54.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":11,"price":434.51,"value":4779.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":1659,"source":{"system":"sec-edgar","filing":"0000059478-23-000180","document":"wf-form4_168426897503157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000180/wf-form4_168426897503157.xml","form_type":"4"}},{"id":56631,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-19T20:33:08.000Z","date":"2023-04-17","kind":"grant","planned":false,"acquired":true,"shares":13,"price":372.35,"value":4840.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":1648,"source":{"system":"sec-edgar","filing":"0000059478-23-000154","document":"wf-form4_168193637640401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000154/wf-form4_168193637640401.xml","form_type":"4"}},{"id":57221,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-22T20:16:49.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":15,"price":333.6,"value":5004.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":1635,"source":{"system":"sec-edgar","filing":"0000059478-23-000135","document":"wf-form4_167951619779073.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000135/wf-form4_167951619779073.xml","form_type":"4"}},{"id":58417,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-22T21:59:01.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":15,"price":327.51,"value":4912.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":1614,"source":{"system":"sec-edgar","filing":"0000059478-23-000096","document":"wf-form4_167710312267960.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000096/wf-form4_167710312267960.xml","form_type":"4"}},{"id":2016675,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-14T17:47:00.000Z","date":"2022-10-03","kind":"gift","acquired":false,"shares":49624,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14270,"source":{"system":"sec-edgar","filing":"0000899243-23-005028","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805387/000089924323005028/doc5.xml","form_type":"5"}},{"id":60141,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-19T21:46:26.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":14,"price":357.74,"value":5008.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":1599,"source":{"system":"sec-edgar","filing":"0000059478-23-000014","document":"wf-form4_167416476756500.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000014/wf-form4_167416476756500.xml","form_type":"4"}},{"id":60557,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T22:15:59.000Z","date":"2022-12-19","kind":"grant","acquired":true,"shares":28,"price":357.78,"value":10017.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":1585,"source":{"system":"sec-edgar","filing":"0000059478-22-000289","document":"wf-form4_167157454149342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000289/wf-form4_167157454149342.xml","form_type":"4"}},{"id":61435,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T22:40:51.000Z","date":"2022-11-21","kind":"grant","acquired":true,"shares":498,"price":361.17,"value":179862.66,"ownership":{"direct":true},"balance_after":1554,"source":{"system":"sec-edgar","filing":"0000059478-22-000274","document":"wf-form4_166915683557821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000274/wf-form4_166915683557821.xml","form_type":"4"}},{"id":61434,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T22:40:51.000Z","date":"2022-11-21","kind":"grant","acquired":true,"shares":27,"price":361.17,"value":9751.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":1056,"source":{"system":"sec-edgar","filing":"0000059478-22-000274","document":"wf-form4_166915683557821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000274/wf-form4_166915683557821.xml","form_type":"4"}},{"id":62573,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-19T20:24:38.000Z","date":"2022-10-17","kind":"grant","acquired":true,"shares":30,"price":332.76,"value":9982.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":1029,"source":{"system":"sec-edgar","filing":"0000059478-22-000245","document":"wf-form4_166621102231184.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000245/wf-form4_166621102231184.xml","form_type":"4"}},{"id":63241,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-21T20:47:58.000Z","date":"2022-09-19","kind":"grant","acquired":true,"shares":33,"price":305.09,"value":10067.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":999,"source":{"system":"sec-edgar","filing":"0000059478-22-000229","document":"wf-form4_166379325657180.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000229/wf-form4_166379325657180.xml","form_type":"4"}},{"id":64197,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-16T20:27:40.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":32,"price":313.94,"value":10046.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":963,"source":{"system":"sec-edgar","filing":"0000059478-22-000213","document":"wf-form4_166068164395088.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000213/wf-form4_166068164395088.xml","form_type":"4"}},{"id":64816,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-20T00:05:47.000Z","date":"2022-07-18","kind":"grant","acquired":true,"shares":31,"price":321.77,"value":9974.87,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":931,"source":{"system":"sec-edgar","filing":"0000059478-22-000184","document":"wf-form4_165827552636440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000184/wf-form4_165827552636440.xml","form_type":"4"}},{"id":2220280,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-28T16:14:04.000Z","date":"2022-06-24","kind":"exercise","acquired":false,"shares":14270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"14,270 RSUs vested on June 24, 2022, the third anniversary of the vesting commencement date of June 24, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"14,270 RSUs vested on June 24, 2022, the third anniversary of the vesting commencement date of June 24, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14270},"source":{"system":"sec-edgar","filing":"0000899243-22-024387","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805387/000089924322024387/doc4.xml","form_type":"4"}},{"id":2220279,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-28T16:14:04.000Z","date":"2022-06-24","kind":"exercise","acquired":true,"shares":14270,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":63894,"source":{"system":"sec-edgar","filing":"0000899243-22-024387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805387/000089924322024387/doc4.xml","form_type":"4"}},{"id":65178,"issuer":{"id":1763,"kind":"organization","name":"Mastercard Inc","symbol":"MA"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-06-23T20:18:12.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock unit award pursuant to the terms of a stockholder-approved non-employee director equity compensation plan. The award was fully vested on June 21, 2022, the date of grant, but will be settled on June 21, 2026."}],"balance_after":3691,"source":{"system":"sec-edgar","filing":"0001141391-22-000123","document":"wf-form4_165601547188030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1141391/000114139122000123/wf-form4_165601547188030.xml","form_type":"4"}},{"id":65209,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-22T21:31:49.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":33,"price":297.34,"value":9812.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":900,"source":{"system":"sec-edgar","filing":"0000059478-22-000165","document":"wf-form4_165593349399331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000165/wf-form4_165593349399331.xml","form_type":"4"}},{"id":2230076,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-16T16:41:57.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":23459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to this option shall vest and become exercisable on the earlier of: (i) the one-year anniversary of the Grant Date, or (ii) the next annual meeting of stockholders of the Company occurring after the Grant Date."}],"balance_after":23459,"derivative":{"exercise_price":24.35,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":23459},"source":{"system":"sec-edgar","filing":"0000899243-22-022826","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805387/000089924322022826/doc4.xml","form_type":"4"}},{"id":2233895,"issuer":{"id":4234,"kind":"organization","name":"Warby Parker Inc.","symbol":"WRBY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-06-14T01:01:48.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":16559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of fully-vested restricted stock units (\"RSUs\"), granted pursuant to the Warby Parker Inc. Amended and Restated Non-Employee Director Compensation Program. Each RSU represents a right to receive one share of Class A Common Stock. The RSUs will be settled in shares of Class A Common Stock following the earliest to occur of: (i) the director's separation from service; (ii) a change in control of the Issuer; (iii) the director's death; or (iv) December 17, 2026."}],"balance_after":46115,"source":{"system":"sec-edgar","filing":"0001104659-22-070667","document":"tm2218339-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262388/000110465922070667/tm2218339-2_4seq1.xml","form_type":"4"}},{"id":66111,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-18T20:42:24.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":33,"price":299.38,"value":9879.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":864,"source":{"system":"sec-edgar","filing":"0000059478-22-000153","document":"wf-form4_165290650982068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000153/wf-form4_165290650982068.xml","form_type":"4"}},{"id":67360,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-19T20:29:16.000Z","date":"2022-04-18","kind":"grant","acquired":true,"shares":33,"price":298.82,"value":9861.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":831,"source":{"system":"sec-edgar","filing":"0000059478-22-000127","document":"wf-form4_165040013132753.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000127/wf-form4_165040013132753.xml","form_type":"4"}},{"id":68347,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-22T20:52:42.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":34,"price":289.64,"value":9847.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":798,"source":{"system":"sec-edgar","filing":"0000059478-22-000104","document":"wf-form4_164798234545441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000104/wf-form4_164798234545441.xml","form_type":"4"}},{"id":70172,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-24T22:09:37.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":41,"price":239.13,"value":9804.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":761,"source":{"system":"sec-edgar","filing":"0000059478-22-000079","document":"wf-form4_164574055973722.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000079/wf-form4_164574055973722.xml","form_type":"4"}},{"id":72929,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-20T22:27:46.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":40,"price":247.07,"value":9882.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service."}],"balance_after":720,"source":{"system":"sec-edgar","filing":"0000059478-22-000011","document":"wf-form4_164271765095001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000011/wf-form4_164271765095001.xml","form_type":"4"}},{"id":76263,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-17T21:42:47.000Z","date":"2021-11-15","kind":"grant","acquired":true,"shares":677,"price":258.43,"value":174957.11,"ownership":{"direct":true},"balance_after":677,"source":{"system":"sec-edgar","filing":"0000059478-21-000218","document":"wf-form4_163718534875121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947821000218/wf-form4_163718534875121.xml","form_type":"4"}},{"id":2547045,"issuer":{"id":4234,"kind":"organization","name":"Warby Parker Inc.","symbol":"WRBY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-07T01:00:54.000Z","date":"2021-10-04","kind":"exercise","acquired":false,"shares":20383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock purchase right is fully vested and will expire on November 2, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This stock purchase right is fully vested and will expire on November 2, 2021."}],"balance_after":0,"derivative":{"exercise_price":24.53,"underlying":"Class A Common Stock","underlying_shares":20383},"source":{"system":"sec-edgar","filing":"0001628280-21-019789","document":"wf-form4_163356843520886.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1262388/000162828021019789/wf-form4_163356843520886.xml","form_type":"4"}},{"id":2547044,"issuer":{"id":4234,"kind":"organization","name":"Warby Parker Inc.","symbol":"WRBY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-10-07T01:00:54.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":20383,"price":53.52,"value":1090898.16,"ownership":{"direct":true},"balance_after":9173,"source":{"system":"sec-edgar","filing":"0001628280-21-019789","document":"wf-form4_163356843520886.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1262388/000162828021019789/wf-form4_163356843520886.xml","form_type":"4"}},{"id":2547043,"issuer":{"id":4234,"kind":"organization","name":"Warby Parker Inc.","symbol":"WRBY"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-10-07T01:00:54.000Z","date":"2021-10-04","kind":"exercise","acquired":true,"shares":20383,"price":24.53,"value":499994.99,"ownership":{"direct":true},"balance_after":29556,"source":{"system":"sec-edgar","filing":"0001628280-21-019789","document":"wf-form4_163356843520886.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262388/000162828021019789/wf-form4_163356843520886.xml","form_type":"4"}},{"id":85291,"issuer":{"id":1763,"kind":"organization","name":"Mastercard Inc","symbol":"MA"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-24T20:27:40.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock unit award pursuant to the terms of a stockholder-approved non-employee director equity compensation plan.  The award was fully vested on June 22, 2021, the date of grant, but will be settled on June 22, 2025."}],"balance_after":2950,"source":{"system":"sec-edgar","filing":"0001141391-21-000132","document":"wf-form4_162456642280516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1141391/000114139121000132/wf-form4_162456642280516.xml","form_type":"4"}},{"id":2656015,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-24T17:32:43.000Z","date":"2021-06-24","kind":"exercise","acquired":false,"shares":14270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"14,270 RSUs vested on June 24, 2021, the second anniversary of the vesting commencement date of June 24, 2019 (the \"Vesting Commencement Date\"), with the remainder vesting on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service relationship with the Issuer through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"14,270 RSUs vested on June 24, 2021, the second anniversary of the vesting commencement date of June 24, 2019 (the \"Vesting Commencement Date\"), with the remainder vesting on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service relationship with the Issuer through each such date."}],"balance_after":14270,"derivative":{"underlying":"Common Stock","underlying_shares":14270},"source":{"system":"sec-edgar","filing":"0000899243-21-025758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805387/000089924321025758/doc4.xml","form_type":"4"}},{"id":2656014,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T17:32:43.000Z","date":"2021-06-24","kind":"exercise","acquired":true,"shares":14270,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":49624,"source":{"system":"sec-edgar","filing":"0000899243-21-025758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805387/000089924321025758/doc4.xml","form_type":"4"}},{"id":2659060,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-22T18:31:45.000Z","date":"2021-06-17","kind":"purchase","acquired":true,"shares":21084,"price":13.06,"value":275357.04,"ownership":{"direct":true},"balance_after":35354,"source":{"system":"sec-edgar","filing":"0000899243-21-025352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805387/000089924321025352/doc4.xml","form_type":"4"}},{"id":2670344,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-14T20:11:46.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":58003,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to this option shall vest and become exercisable on the earlier of: (i) the one year anniversary of the Grant Date, or (ii) the next annual meeting of stockholders of the Company occurring after the Grant Date."}],"balance_after":58003,"derivative":{"exercise_price":13.93,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":58003},"source":{"system":"sec-edgar","filing":"0000899243-21-023721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805387/000089924321023721/doc4.xml","form_type":"4"}},{"id":2688718,"issuer":{"id":3583,"kind":"organization","name":"Brixmor Property Group Inc."},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-01T20:17:04.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock."}],"balance_after":37161,"source":{"system":"sec-edgar","filing":"0001123292-21-000927","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262388/000112329221000927/edgar.xml","form_type":"4"}},{"id":103838,"issuer":{"id":1763,"kind":"organization","name":"Mastercard Inc","symbol":"MA"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-06-18T20:10:52.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":707,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock unit award pursuant to the terms of a stockholder-approved non-employee director equity compensation plan.  The award was fully vested on June 16, 2020, the date of grant, but will be settled on June 16, 2024."}],"balance_after":2328,"source":{"system":"sec-edgar","filing":"0001141391-20-000137","document":"wf-form4_159251103457108.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1141391/000114139120000137/wf-form4_159251103457108.xml","form_type":"4"}},{"id":3128887,"issuer":{"id":3583,"kind":"organization","name":"Brixmor Property Group Inc."},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Greene-Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-01T20:07:22.000Z","date":"2020-06-01","kind":"grant","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock."}],"balance_after":32161,"source":{"system":"sec-edgar","filing":"0001123292-20-000837","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262388/000112329220000837/edgar.xml","form_type":"4"}},{"id":115728,"issuer":{"id":1763,"kind":"organization","name":"Mastercard Inc","symbol":"MA"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Greene-Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-06-27T19:21:00.000Z","date":"2019-06-25","kind":"grant","acquired":true,"shares":828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock unit award pursuant to the terms of a stockholder-approved non-employee director equity compensation plan.  The award was fully vested on June 25, 2019, the date of grant, but will settle on June 25, 2023."}],"balance_after":1621,"source":{"system":"sec-edgar","filing":"0001141391-19-000114","document":"wf-form4_156166324519384.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1141391/000114139119000114/wf-form4_156166324519384.xml","form_type":"4"}},{"id":3500303,"issuer":{"id":3583,"kind":"organization","name":"Brixmor Property Group Inc."},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Greene-Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-05T20:13:27.000Z","date":"2019-06-05","kind":"grant","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock."}],"balance_after":27161,"source":{"system":"sec-edgar","filing":"0001123292-19-000864","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262388/000112329219000864/edgar.xml","form_type":"4"}},{"id":122084,"issuer":{"id":1763,"kind":"organization","name":"Mastercard Inc","symbol":"MA"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Greene-Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2018-12-04T21:26:34.000Z","date":"2018-12-03","kind":"grant","acquired":true,"shares":543,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock unit award pursuant to the terms of a stockholder-approved non-employee director equity compensation plan.  The award was fully vested on December 3, 2018, the date of grant, but will be settled on December 3, 2022."}],"balance_after":793,"source":{"system":"sec-edgar","filing":"0001141391-18-000143","document":"wf-form4_154395877713766.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1141391/000114139118000143/wf-form4_154395877713766.xml","form_type":"4"}},{"id":3903167,"issuer":{"id":3583,"kind":"organization","name":"Brixmor Property Group Inc."},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Greene-Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-06T21:00:16.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock."}],"balance_after":22161,"source":{"system":"sec-edgar","filing":"0001123292-18-000802","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262388/000112329218000802/edgar.xml","form_type":"4"}},{"id":3997915,"issuer":{"id":3583,"kind":"organization","name":"Brixmor Property Group Inc."},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Greene-Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-13T21:37:24.000Z","date":"2018-03-09","kind":"purchase","acquired":true,"shares":750,"price":15.52,"value":11640.0,"ownership":{"direct":true},"balance_after":17161,"source":{"system":"sec-edgar","filing":"0001123292-18-000538","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262388/000112329218000538/edgar.xml","form_type":"4"}},{"id":4139084,"issuer":{"id":3583,"kind":"organization","name":"Brixmor Property Group Inc."},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Greene-Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-07T22:01:31.000Z","date":"2017-12-06","kind":"purchase","acquired":true,"shares":1411,"price":17.71,"value":24988.81,"ownership":{"direct":true},"balance_after":16411,"source":{"system":"sec-edgar","filing":"0001123292-17-001747","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262388/000112329217001747/edgar.xml","form_type":"4"}},{"id":4223900,"issuer":{"id":173568,"kind":"organization","name":"WHOLE FOODS MARKET INC","symbol":"WFM"},"owners":[{"id":10431,"kind":"person","name":"Sulzberger Gabrielle","position":1,"cik":"0001262388","reported_name":"Greene-Sulzberger Gabrielle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-08-28T16:57:45.000Z","date":"2017-08-28","kind":"disposition_to_issuer","acquired":false,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the merger agreement, each outstanding stock option was cancelled and converted into the right to receive an amount in cash equal to the product of (a) the number of shares subject to such option multiplied by (b) the excess, if any, of the merger consideration of $42.00 over the exercise price per share of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was exercisable in four equal annual installments beginning on the first anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":35.99,"expiration_date":"2024-05-19","underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0000865436-17-000215","document":"wf-form4_150395385122737.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/865436/000086543617000215/wf-form4_150395385122737.xml","form_type":"4"}}],"next_cursor":"2017-08-28T16:57:45.000000Z,4223900"}